𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Open-Label Support for Duloxetine for the Treatment of Panic Disorder

✍ Scribed by Naomi M. Simon; Rebecca E. Kaufman; Elizabeth A. Hoge; John J. Worthington; Nannette N. Herlands; Maryann E. Owens; Mark H. Pollack

Book ID
118076629
Publisher
John Wiley and Sons
Year
2009
Tongue
English
Weight
656 KB
Volume
15
Category
Article
ISSN
1755-5930

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Duloxetine in the treatment of adolescen
Duloxetine in the treatment of adolescents with attention deficit/hyperactivity disorder: an open-label study
✍ Javad Mahmoudi-Gharaei; Nasrin Dodangi; Mehdi Tehrani-Doost; Toktam Faghihi πŸ“‚ Article πŸ“… 2011 πŸ› John Wiley and Sons 🌐 English βš– 90 KB πŸ‘ 2 views

Objective The main aim of this study was to explore the efficacy and safety of duloxetine, a serotonin and norepinephrine reuptake inhibitor, in the treatment of adolescents with attention deficit/hyperactivity disorder (ADHD). Methods Seventeen adolescents aged 11-18 years, diagnosed with ADHD, par

The efficacy of reboxetine in the treatm
The efficacy of reboxetine in the treatment-refractory patients with panic disorder: an open label study
✍ P. N. Dannon; I. Iancu; L. Grunhaus πŸ“‚ Article πŸ“… 2002 πŸ› John Wiley and Sons 🌐 English βš– 57 KB πŸ‘ 2 views

## Abstract ## Background and Objective Selective serotonin reuptake inhibitors (SSRIs) are currently the first‐line treatment for panic disorder, although up to 30% of patients either do not respond to SSRIs or withdraw due to adverse events. Reboxetine, a selective norepinephrine reuptake inhibi

Clonazepam for the Treatment of Panic Di
Clonazepam for the Treatment of Panic Disorder
✍ E. Nardi, Antonio; Machado, Sergio; Ferreira Almada, Leonardo; Paes, Flavia; Car πŸ“‚ Article πŸ“… 2013 πŸ› Bentham Science Publishers 🌐 English βš– 287 KB